HOME Top Market Reports Lateral Flow Assay Market by Product (Reader, Kits) Application (Clinical Testing (Pregnancy, Infectious Disease, Cholestrol, Cardiac Marker), Veterinary, Drug Development) Technique (Sandwich, Competitive, Multiplex) End User - Global Forecast to 2020

Lateral Flow Assay Market by Product (Reader, Kits) Application (Clinical Testing (Pregnancy, Infectious Disease, Cholestrol, Cardiac Marker), Veterinary, Drug Development) Technique (Sandwich, Competitive, Multiplex) End User - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: March 2016
Report Code: MD 4158

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global lateral flow assay market is projected to reach USD 6.78 Billion by 2020, growing at a CAGR of 8.3% from 2015 to 2020. Over the last few years, substantial growth and rapid technological advancements have been witnessed in this market. This market is majorly driven by the rising geriatric population, high prevalence of infectious diseases, rising usage of home-based lateral flow assay tests, improved focus on decentralized or point-of-care diagnostic testing, and increasing application of lateral flow assay techniques in clinical diagnostics. However, difficulty in obtaining regulatory approvals due to the constantly changing standards, variance in test results, and insufficient reimbursements for lateral flow assay procedures are posing several challenges to the overall growth of the market.

The lateral flow assay market in North America and Europe is growing at a significant rate owing to the rising geriatric population and increasing incidence of associated chronic disorders; presence of highly developed healthcare systems in these regions; immense application scope, coupled with the easy access to lateral flow tests through diagnostic service providers; and the presence of major market players in these regions. However, in the coming years, the Asia-Pacific region is expected to become the growth center for the global market. Markets in China, Japan, and India are expected to witness significant growth between 2015 and 2020 primarily due to the growing healthcare awareness among the population in these countries, presence of less stringent regulations, improving healthcare infrastructure, and increasing demand for quality healthcare at low costs.

The top five players in the global market account for ~80% of the market share. In order to maintain their share, leading players are continuously embracing new technologies and striving to develop and launch advanced products in the market. This strong focus on innovation is helping the industry solve existing challenges and overcome the unmet needs in the market.

Some prominent players in the global lateral flow assay market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories, Inc. (U.S.), and Danaher Corporation (U.S.). In addition to these major players, there are more than 30 players in the global market, including Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Bio-Rad Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and QIAGEN N.V. (Netherlands).

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

Lateral flow assays, also known as immunochromatography assays or strip tests, are simple devices intended to detect the presence (or absence) of a target analyte in a sample without the need for specialized and costly equipment. It involves the use of techniques such as sandwich assay, competitive assay, and multiplex detection assay. These techniques are successfully used in the field of medical diagnostics such as in clinical/point-of-care testing, veterinary diagnostics, and drug development & quality testing. High prevalence of infectious diseases, rising usage of home-based lateral flow assay tests, improved focus on decentralized or point-of-care diagnostic testing, and increasing application of lateral flow assay techniques in clinical diagnostics are expected to boost the growth of the market.

This research report categorizes the lateral flow assay market into the following segments:

  • Global Lateral Flow Assay Market, by Technique
    • Sandwich Assay
    • Competitive Assay
    • Multiplex Detection Assay
  • Global Lateral Flow Assay Market, by Product
    • Kits & Reagents
    • Lateral Flow Readers
      • Digital/Mobile Readers
      • Benchtop Readers
  • Global Lateral Flow Assay Market, by Application
    • Clinical/Point-of-Care Testing
      • Infectious Disease Testing
      • Cardiac Marker Testing
      • Pregnancy & Fertility Testing
      • Cholesterol & Lipid Testing
      • Drugs-of-abuse Testing
      • Other Tests
    • Veterinary Diagnostics
    • Drug Development & Quality Testing
  • Global Lateral Flow Assay Market, by End User
    • Hospitals & Clinics
    • Home Care
    • Diagnostic Laboratories
    • Pharmaceutical and Biotechnology Companies
  • Global Lateral Flow Assay Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific (APAC)
      • China
      • Japan
      • India
      • Rest of APAC
    • Rest of the World (RoW)
      • Latin America
      • Middle East & Africa

Target Audience

  • Lateral Flow Assay Device Manufacturers and Distributors
  • Healthcare Institutions (Hospitals, Laboratories, Medical Schools, and Outpatient Clinics)
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Government Associations
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per a client’s specific requirements. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific lateral flow assay market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Latin American lateral flow assay market into Brazil, Argentina, and the Rest of Latin America

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Secondary Sources
           2.5.1 Key Data From Secondary Sources
    2.6 Primary Sources
           2.6.1 Key Data From Primary Sources
           2.6.2 Key Industry Insights
    2.7 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 35)
    4.1 Market Overview
    4.2 Asia-Pacific Market, By Technology
    4.3 Market: Geographic Snapshot
    4.4 Market: Geographic Mix
    4.5 Market: Developing vs  Developed Countries/Regions

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Product
           5.2.2 By Technique
           5.2.3 By Application
           5.2.4 By End User
    5.3 Key Market Dynamics
           5.3.1 Market Drivers
                    5.3.1.1 High Prevalence of Infectious Diseases
                    5.3.1.2 Rapidly Increasing Geriatric Population
                    5.3.1.3 Increasing Usage of Home-Based Lateral Flow Assay Devices
                    5.3.1.4 Growing Demand for Point-Of-Care Testing
                    5.3.1.5 Rising Healthcare Costs
           5.3.2 Restraints
                    5.3.2.1 Reluctance Towards Changing Existing Diagnostics Practices
                    5.3.2.2 Implementation of Excise Duty on Medical Devices By the U.S. Government
                    5.3.2.3 Stringent and Time-Consuming Regulatory Policies
           5.3.3 Opportunities
                    5.3.3.1 Growing Application of Lateral Flow Assay Tests in Clinical Diagnostics
                    5.3.3.2 Miniaturization and Technological Advancements
                    5.3.3.3 Rising Focus on Microfluidics Devices
           5.3.4 Challenges
                    5.3.4.1 Limited Reimbursement for Lateral Flow Assay Products

6 Industry Insights (Page No. - 49)
    6.1 Introduction
    6.2 Regulatory Analysis
    6.3 Value Chain Analysis
    6.4 Supply Chain Analysis

7 Global Lateral Flow Assay Market, By Product (Page No. - 53)
    7.1 Introduction
    7.2 Kits & Reagents
    7.3 Lateral Flow Readers
           7.3.1 Digital/Mobile Readers
           7.3.2 Benchtop Readers

8 Global Lateral Flow Assay Market, By Technique (Page No. - 61)
    8.1 Introduction
    8.2 Sandwich Assays
    8.3 Competitive Assays
    8.4 Multiplex Detection Assays

9 Lateral Flow Assay Market, By Application (Page No. - 67)
    9.1 Introduction
    9.2 Clinical/Point-Of-Care Testing
           9.2.1 Infectious Disease Testing
           9.2.2 Cardiac Marker Testing
           9.2.3 Pregnancy and Fertility Testing
                    9.2.3.1 Pregnancy Testing
                    9.2.3.2 Fertility Testing Market
           9.2.4 Cholesterol/Lipid Testing
           9.2.5 Drugs-Of-Abuse Testing
           9.2.6 Other Tests
    9.3 Veterinary Diagnostics
    9.4 Drug Development

10 Global Lateral Flow Assay Market, By End User (Page No. - 84)
     10.1 Introduction
     10.2 Hospitals and Clinics
     10.3 Home Care
     10.4 Diagnostic Laboratories
     10.5 Pharmaceutical and Biotechnology Companies

11 Lateral Flow Assay Market, By Region (Page No. - 91)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Rest of Europe
     11.4 Asia-Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific
     11.5 Rest of the World (RoW)
             11.5.1 Latin America
             11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. - 161)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
             12.3.1 New Product Launches
             12.3.2 Partnerships and Collaborations
             12.3.3 Mergers and Acquisitions
             12.3.4 Expansion

13 Company Profiles (Page No. - 169)
     13.1 Introduction
     13.2 Alere Inc.
             13.2.1 Business Overview
             13.2.2 Products Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 F. Hoffmann-La Roche AG
             13.3.1 Introduction
             13.3.2 Products Offered
             13.3.3 Recent Developments
             13.3.4 MnM View
     13.4 Danaher Corporation
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Recent Developments
             13.4.4 MnM View
     13.5 Abbott Laboratories, Inc.
             13.5.1 Business Overview
             13.5.2 Products Offered
             13.5.3 Recent Developments
             13.5.4 MnM View
     13.6 Siemens AG
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Recent Developments
     13.7 Johnson & Johnson
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Recent Developments
             13.7.4 MnM View
     13.8 Becton, Dickinson and Company
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Recent Developments
     13.9 Biomιrieux SA
             13.9.1 Business Overview
             13.9.2 Products Offered
             13.9.3 Recent Developments
     13.10 Bio-Rad Laboratories, Inc.
             13.10.1 Business Overview
             13.10.2 Products Offered
             13.10.3 Recent Developments
     13.11 Thermo Fisher Scientific, Inc.
             13.11.1 Business Overview
             13.11.2 Products Offered
             13.11.3 Recent Developments
     13.12 Qiagen N.V.
             13.12.1 Business Overview
             13.12.2 Products Offered
             13.12.3 Recent Developments

14 Appendix (Page No. - 200)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Available Customizations
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Related Reports


List of Tables (174 Tables)

Table 1 Prevalence of Infectious Diseases Worldwide (2014)
Table 2 Rising Demand for Point-Of-Care Testing to Boost Market Growth
Table 3 Reluctance Towards Changing Existing Diagnostics Practices to Hinder Market Growth
Table 4 Growing Application of Lateral Flow Assay Tests in Clinical Diagnostics to Provide Significant Growth Opportunities for Market Players
Table 5 Limited Reimbursement for Lateral Flow Assay Products is A Major Market Challenge
Table 6 Regulatory Standard/Approval Required for Lateral Flow Immunoassay Products, By Country/Region
Table 7 Global Market, By Product (2013-2020)
Table 8 Popular Labeling Methods
Table 9 Kits & Reagents Market Size, By Country, 2013-2020 (USD Million)
Table 10 Lateral Flow Readers Market Size, By Product, 2013-2020 (USD Million)
Table 11 Lateral Flow Readers Market Size, By Country, 2013-2020 (USD Million)
Table 12 Digital/Mobile Readers Market Size, By Country, 2013-2020 (USD Million)
Table 13 Benchtop Readers Market Size, By Country, 2013-2020 (USD Million)
Table 14 Global Market Size, By Technique,  2013–2020 (USD Million)
Table 15 Lateral Flow Sandwich Assays Market Size, By Country,  2013–2020 (USD Million)
Table 16 Lateral Flow Competitive Assays Market Size, By Country,  2013–2020 (USD Million)
Table 17 Lateral Flow Multiplex Detection Assays Market Size, By Country,  2013–2020 (USD Million)
Table 18 Global Market Size, By Application,  2013-2020 (USD Million)
Table 19 Overview of Lateral Flow Assays: Detection of Infectious Agents, Metabolic Disorders, and Toxic Compounds
Table 20 Market Size for Clinical/Point-Of-Care Testing, By Type, 2013-2020 (USD Million)
Table 21 Market Size for Clinical/Point-Of-Care Testing,  By Country, 2013-2020 (USD Million)
Table 22 Market Size for Infectious Disease Testing, By Country, 2013-2020 (USD Million)
Table 23 Market Size for Cardiac Marker Testing, By Country, 2013-2020 (USD Million)
Table 24 Market Size for Pregnancy and Fertility Testing, By Type, 2013-2020 (USD Million)
Table 25 Market Size for Pregnancy and Fertility Testing,  By Country, 2013-2020 (USD Million)
Table 26 Market Size for Pregnancy Testing, By Country,  2013-2020 (USD Million)
Table 27 Market Size for Fertility Testing, By Country,  2013-2020 (USD Million)
Table 28 Market Size for Cholesterol/Lipid Testing, By Country, 2013-2020 (USD Million)
Table 29 Usual Cut-Off Concentrations for Various Drugs in Point-Of-Care Testing Devices for Urine Specimens
Table 30 Market Size for Drugs-Of-Abuse Testing, By Country, 2013-2020 (USD Million)
Table 31 Market Size for Other Tests, By Country,  2013-2020 (USD Million)
Table 32 Market Size for Veterinary Diagnostics, By Country,  2013-2020 (USD Million)
Table 33 Market Size for Drug Development, By Country,  2013-2020 (USD Million)
Table 34 Global Market Size, By End User, 2013-2020 (USD Million)
Table 35 Market Size for Hospitals and Clinics, By Country,  2013-2020 (USD Million)
Table 36 Market Size for Home Care, By Country,  2013-2020 (USD Million)
Table 37 Market Size for Diagnostic Laboratories, By Country, 2013-2020 (USD Million)
Table 38 Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2013-2020 (USD Million)
Table 39 North America: Market Size, By Country,  2013–2020 (USD Million)
Table 40 North America: Market Size, By Product,  2013–2020 (USD Million)
Table 41 North America: Lateral Flow Readers Market Size, By Type,  2013–2020 (USD Million)
Table 42 North America: Market Size, By Technique,  2013–2020 (USD Million)
Table 43 North America: Market Size, By Application,  2013–2020 (USD Million)
Table 44 North America: Market Size for Clinical/Point-Of-Care Testing, By Type, 2013–2020 (USD Million)
Table 45 North America: Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 46 North America: Market Size, By End User,  2013–2020 (USD Million)
Table 47 U.S.: Market Size, By Product, 2013–2020 (USD Million)
Table 48 U.S.: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 49 U.S.: Market Size, By Technique, 2013–2020 (USD Million)
Table 50 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 51 U.S.: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 52 U.S.: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 53 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 54 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 55 Canada: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 56 Canada: Market Size, By Technique,  2013–2020 (USD Million)
Table 57 Canada: Market Size, By Application,  2013–2020 (USD Million)
Table 58 Canada: Market Size for Clinical/Point-Of-Care Testing, By Type, 2013–2020 (USD Million)
Table 59 Canada: Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 60 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 61 Europe: Market Size, By Country, 2013–2020 (USD Million)
Table 62 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 63 Europe: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 64 Europe: Market Size, By Technique,  2013–2020 (USD Million)
Table 65 Europe: Market Size, By Application,  2013–2020 (USD Million)
Table 66 Europe: Market Size for Clinical/Point-Of-Care Testing, By Type, 2013–2020 (USD Million)
Table 67 Europe: Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 68 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 69 Germany: Market Size, By Product,  2013–2020 (USD Million)
Table 70 Germany: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 71 Germany: Market Size, By Technique,  2013–2020 (USD Million)
Table 72 Germany: Market Size, By Application,  2013–2020 (USD Million)
Table 73 Germany: Market Size for Clinical/Point-Of-Care Testing, By Type, 2013–2020 (USD Million)
Table 74 Germany: Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 75 Germany: Market Size, By End User,  2013–2020 (USD Million)
Table 76 France: Market Size, By Product, 2013–2020 (USD Million)
Table 77 France: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 78 France: Market Size, By Technique,  2013–2020 (USD Million)
Table 79 France: Market Size, By Application,  2013–2020 (USD Million)
Table 80 France: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 81 France: Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 82 France: Market Size, By End User, 2013–2020 (USD Million)
Table 83 U.K.: Market Size, By Product, 2013–2020 (USD Million)
Table 84 U.K.: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 85 U.K.: Market Size, By Technique, 2013–2020 (USD Million)
Table 86 U.K.: Market Size, By Application, 2013–2020 (USD Million)
Table 87 U.K.: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 88 U.K.: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 89 U.K.: Market Size, By End User, 2013–2020 (USD Million)
Table 90 Italy: Market Size, By Product, 2013–2020 (USD Million)
Table 91 Italy: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 92 Italy: Market Size, By Technique, 2013–2020 (USD Million)
Table 93 Italy: Market Size, By Application, 2013–2020 (USD Million)
Table 94 Italy: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 95 Italy: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 96 Italy: Market Size, By End User, 2013–2020 (USD Million)
Table 97 Spain: Market Size, By Product, 2013–2020 (USD Million)
Table 98 Spain: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 99 Spain: Market Size, By Technique, 2013–2020 (USD Million)
Table 100 Spain: Market Size, By Application,  2013–2020 (USD Million)
Table 101 Spain: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 102 Spain: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 103 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 104 RoE: Market Size, By Product, 2013–2020 (USD Million)
Table 105 RoE: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 106 RoE: Market Size, By Technique, 2013–2020 (USD Million)
Table 107 RoE: Market Size, By Application, 2013–2020 (USD Million)
Table 108 RoE: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 109 RoE: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 110 RoE: Market Size, By End User, 2013–2020 (USD Million)
Table 111 APAC: Percentage of Total Deaths Caused By Non-Communicable Diseases,  By Country, 2013
Table 112 APAC: Market Size, By Country, 2013–2020 (USD Million)
Table 113 APAC: Market Size, By Product, 2013–2020 (USD Million)
Table 114 APAC: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 115 APAC: Market Size, By Technique, 2013–2020 (USD Million)
Table 116 APAC: Market Size, By Application, 2013–2020 (USD Million)
Table 117 APAC: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 118 APAC: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 119 APAC: Market Size, By End User, 2013–2020 (USD Million)
Table 120 Japan: Market Size, By Product, 2013–2020 (USD Million)
Table 121 Japan: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 122 Japan: Market Size, By Technique, 2013–2020 (USD Million)
Table 123 Japan: Market Size, By Application,  2013–2020 (USD Million)
Table 124 APAC: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 125 Japan: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 126 Japan: Market Size, By End User, 2013–2020 (USD Million)
Table 127 China: Market Size, By Product, 2013–2020 (USD Million)
Table 128 China: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 129 China: Market Size, By Technique, 2013–2020 (USD Million)
Table 130 China: Market Size, By Application,  2013–2020 (USD Million)
Table 131 China: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 132 China: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 133 China: Market Size, By End User, 2013–2020 (USD Million)
Table 134 India: Market Size, By Product, 2013–2020 (USD Million)
Table 135 India: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 136 India: Market Size, By Technique, 2013–2020 (USD Million)
Table 137 India: Market Size, By Application, 2013–2020 (USD Million)
Table 138 India: Market Size for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 139 India: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 140 India: Market Size, By End User, 2013–2020 (USD Million)
Table 141 RoAPAC: Market Size, By Product, 2013–2020 (USD Million)
Table 142 RoAPAC: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 143 RoAPAC: Market Size, By Technique,  2013–2020 (USD Million)
Table 144 RoAPAC: Market Size, By Application,  2013–2020 (USD Million)
Table 145 RoAPAC: Market Size for Clinical/Point-Of-Care Testing, By Type, 2013–2020 (USD Million)
Table 146 RoAPAC: Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 147 RoAPAC: Market Size, By End User, 2013–2020 (USD Million)
Table 148 RoW: Market Size, By Region, 2013–2020 (USD Million)
Table 149 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 150 RoW: Lateral Flow Readers Market Size, By Type, 2013–2020 (USD Million)
Table 151 RoW: Market Size, By Technique, 2013–2020 (USD Million)
Table 152 RoW: Market Size, By Application, 2013–2020 (USD Million)
Table 153 RoW: Market for Clinical/Point-Of-Care Testing,  By Type, 2013–2020 (USD Million)
Table 154 RoW: Market Size for Pregnancy and Fertility Testing,  By Type, 2013–2020 (USD Million)
Table 155 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 156 Latin America: Market Size, By Product,  2013–2020 (USD Million)
Table 157 Latin America: Lateral Flow Readers Market Size, By Type,  2013–2020 (USD Million)
Table 158 Latin America: Market Size, By Technique,  2013–2020 (USD Million)
Table 159 Latin America: Market Size, By Application, 2013–2020 (USD Million)
Table 160 Latin America: Market for Clinical/Point-Of-Care Testing, By Type, 2013–2020 (USD Million)
Table 161 Latin America: Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 162 Latin America: Lateral Flow Assay Market Size, By End User, 2013–2020 (USD Million)
Table 163 Middle East and Africa: Lateral Flow Assay Market Size, By Product,  2013–2020 (USD Million)
Table 164 Middle East and Africa: Lateral Flow Readers Market Size, By Type,  2013–2020 (USD Million)
Table 165 Middle East and Africa: Lateral Flow Assay Market Size, By Technique,  2013–2020 (USD Million)
Table 166 Middle East and Africa: Lateral Flow Assay Market Size, By Application,  2013–2020 (USD Million)
Table 167 Middle East and Africa: Lateral Flow Assay Market for Clinical/Point-Of-Care Testing, By Type, 2013–2020 (USD Million)
Table 168 Middle East and Africa: Lateral Flow Assay Market Size for Pregnancy and Fertility Testing, By Type, 2013–2020 (USD Million)
Table 169 Middle East and Africa: Lateral Flow Assay Market Size, By End User,  2013–2020 (USD Million)
Table 170 Growth Strategy Matrix, 2012–2016
Table 171 Recent Developments, 2015
Table 172 Recent Developments, 2015–2016
Table 173 Recent Developments, 2014–2016
Table 174 Recent Developments, 2012–2014


List of Figures (48 Figures)

Figure 1 Research Design
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Lateral Flow Assay Market Size, By Product, 2015 vs  2020 (USD Million)
Figure 7 Lateral Flow Assay Market Size, By Technique, 2015 vs  2020 (USD Million)
Figure 8 Lateral Flow Assay Market Size, By Application, 2015 vs  2020 (USD Million)
Figure 9 Lateral Flow Assay Market Size, By End User, 2015 vs  2020 (USD Million)
Figure 10 Geographical Snapshot of the Lateral Flow Assay Market, 2014
Figure 11 Rising Demand for Point-Of-Care Testing to Drive Market Growth During the Forecast Period
Figure 12 The Sandwich Assays Segment Commanded the Largest Share of the Asia-Pacific Lateral Flow Assay Market in 2014
Figure 13 The U.S. Dominated the Global Lateral Flow Assay Market in 2014
Figure 14 North America to Dominate the Lateral Flow Assay Market During the Forecast Period
Figure 15 China to Register Highest Growth During the Forecast Period
Figure 16 Lateral Flow Assay Market, By Product
Figure 17 Lateral Flow Assay Market, By Technique
Figure 18 Lateral Flow Assay Market, By Application
Figure 19 Lateral Flow Assay Market, By End User
Figure 20 Lateral Flow Assay Market: Drivers, Restraints, Opportunities, & Challenges
Figure 21 Prevalence of HIV Infections Across Globe, 2013
Figure 22 Global Elderly Population, By Region
Figure 23 Lateral Flow Assay Market: Value Chain Analysis (2015)
Figure 24 Lateral Flow Assay Market: Supply Chain Analysis (2015)
Figure 25 Kits & Reagents to Hold the Largest Share of the Global Lateral Flow Assay Market in 2020
Figure 26 Digital/Mobile Readers Will Continue to Dominate the Lateral Flow Readers Market in 2020
Figure 27 The Sandwich Assays Technique Dominates the Global Lateral Flow Assay Market, By Technique, in 2015
Figure 28 Clinical/Point-Of-Care Testing Segment to Dominate the Global Lateral Flow Assay Market From 2015 to 2020
Figure 29 Hospitals and Clinics Will Continue to Dominate the Lateral Flow Assay Market in 2020
Figure 30 Geographic Snapshot (2014): Lateral Flow Assay Market in China Expected to Witness Highest Growth
Figure 31 North America: Lateral Flow Assay Market Snapshot
Figure 32 Europe: Lateral Flow Assay Market Snapshot
Figure 33 APAC Lateral Flow Assay Market Snapshot
Figure 34 New Product Launches—The Most Widely Adopted Growth Strategy Pursued By Leading Players Between 2012 and 2016
Figure 35 Lateral Flow Assay Market Share Analysis, By Key Player, 2014
Figure 36 Battle for Market Share: New Product Launches Was the Key Strategy
Figure 37 Geographic Revenue Mix of the Top Five Players
Figure 38 Company Snapshot: Alere Inc.
Figure 39 Company Snapshot: F. Hoffmann-La Roche AG
Figure 40 Company Snapshot: Danaher Corporation
Figure 41 Company Snapshot: Abbott Laboratories, Inc.
Figure 42 Company Snapshot: Siemens AG
Figure 43 Company Snapshot: Johnson & Johnson
Figure 44 Company Snapshot: Becton, Dickinson and Company
Figure 45 Company Snapshot: Biomιrieux
Figure 46 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 47 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 48 Company Snapshot: Qiagen N.V.

The global lateral flow assay market is estimated to reach USD 6.78 Billion by 2020, growing at a CAGR of 8.3% during the forecast period of 2015 to 2020. The growth in this market is majorly driven by the rising geriatric population, high prevalence of infectious diseases, rising usage of home-based lateral flow assay tests, improved focus on decentralized or point-of-care diagnostic testing, and increasing application of lateral flow assay techniques in clinical diagnostics. However, factors such as difficulty in obtaining regulatory approvals due to the constantly changing standards, variance in test results, and insufficient reimbursements are expected to restrain the growth of this market in the coming years.

The global lateral flow assay market is segmented based on products, techniques, applications, end users, and region. Based on products, the market is segmented into kits & reagents and lateral flow readers. The lateral flow readers market is subsegmented into digital/mobile readers and benchtop readers. In 2014, the kits & reagents segment accounted for the largest share of the global lateral flow assay products market primarily due to the rising use of home-based lateral flow assay tests, and growing focus on decentralized or point-of-care diagnostic testing. This segment will continue to dominate the market during the forecast period.

Based on technique, the market is segmented into sandwich assay, competitive assay, and multiplex detection assay. Based on applications, the lateral flow assay market is segmented into clinical/point-of-care testing, veterinary diagnostics, and drug development & quality testing. The clinical/point-of-care testing segment is further subsegmented into pregnancy & fertility testing, infectious disease testing, cardiac marker testing, drugs-of-abuse testing, and other tests.

The global market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). These regions are further analyzed at a country level. North America represented the largest regional market for lateral flow assays in 2014, followed by Europe, Asia-Pacific, and RoW. North America and Europe are expected to witness a healthy growth rate in coming years owing to the rising geriatric population, easy access to lateral flow tests through diagnostic service providers, and presence of major companies in these regions. On the other hand, the Asia-Pacific region represents the fastest-growing market for lateral flow assay products. The high growth in the Asia-Pacific market is primarily attributed to the increasing healthcare awareness, presence of less stringent regulations, improving healthcare infrastructure, and increasing demand for quality healthcare at low costs.

Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Germany), Danaher Corporation (U.S.), Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Siemens Healthcare (Germany), Thermo Fisher Scientific, Inc. (U.S.), Quidel Corporation (U.S.), and bioMιrieux (France) are the leading players in the global lateral flow assay market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo